Introduction: the global spread of COVID-19 remains unabated in the past few months with a rise in the number of available literature on the novel virus . There are very few paediatric studies and are mainly from developed countries with a paucity of information on the clinical manifestation of COVID-19 disease in African children, including Nigeria.Methods: we described the clinical presentation, laboratory findings, treatment and outcome in a group of five Nigerian children managed at COVID-19 isolation and treatment centre in Nigeria.Results: we managed a total of five children with an age range of 3 months to 8 years in the last four weeks (16th April to 15th May 2020). Three othe five children were males . All the children had close contact with family members that tested positive for COVID-19 . Out of the five children, onhad moderate disease, three had mild symptomatic disease, and one was asymptomatic . Two out of the five children had lymphocytosis . Out of thfour children who had chest radiograph, two had features of pneumonia . Conclusion: COVID-19 is not uncommon in Nigerian children, and all had a confirmed family member with COVID-19 . Besides, contrary to leucopaeniwith lymphopaenia observed in the adult ’ s population, we found lymphocytosis in this cohort and about 50.0% had pneumonic changes on chesradiograph.